drugset / Trial / NCT01158599
This is a Study to Assess the Safety and Immunogenicity of Ixiaro® (IC51) in an Elderly Population
Non-randomizedSingle-groupOpen-labelPrevention
Summary
This is an open-label, uncontrolled phase 4 study to assess the safety and immunogenicity of the Japanese encephalitis (JE) vaccine Ixiaro® (IC51) in an elderly population.
Timeline
- Start
- 2010-06
- Primary completion
- 2011-06
- Completion
- 2011-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | IC51 | Vaccine | 6 ug | Intramuscular |
| Subject | IC51 | Vaccine | 0.5 ml | Intramuscular |